Theranostic nanoparticles (NPs) are promising for opening new windows toward
personalized disease management. Using a single particle capable of both diagnosis and …

Background Glioblastoma is the most devastating primary brain tumor of the central nervous
system in adults. Magnetic nanocarriers may help not only for a targeted delivery of …

Background Glioma represents the most common malignant brain tumor. Outcomes of
surgical resection are often unsatisfactory due to low sensitivity or resolution of imaging …

Although doxorubicin (DOX) is an effective anti-cancer drug with cytotoxicity in a variety of
different tumors, its effectiveness in treating glioblastoma multiforme (GBM) is constrained by …

Glioma is a type of cancer with a very poor prognosis with a survival of around 15 months in
the case of glioblastoma multiforme (GBM). In order to advance in personalized medicine …

We developed a novel, pH-sensitive drug delivery microparticle based on N-palmitoyl
chitosan (NPCS) to transport the superparamagnetic iron oxide (SPIO) and anticancer drug …

Development of efficient nanoparticles (NPs) for cancer therapy remains a challenge. NPs
are required to have high stability, uniform size, sufficient drug loading, targeting capability …

Doxorubicin‐loaded chitosan‐coated superparamagnetic iron oxide nanoparticles (Fe3O4;
SPIO‐NP s) were prepared by coprecipitation and emulsification cross‐linking method and …

Superparamagnetic iron oxide nanoparticles (SPIO-NPs) have great potential to be used in
different pharmaceutical applications, due to their unique and versatile physical and …

With a very poor prognosis and no clear etiology, glioma is the most aggressive cancer in
the brain. Thanks to its versatility, nanomedicine is a promising option to overcome the …